Drug Rehab: Treatment Options and What to Expect

What is drug rehab?

Drug rehab is a broad term for organized treatment intended to reduce or stop harmful drug use, improve health and functioning, address related mental-health and life problems, and support continuing recovery. It may be delivered by one provider or by several coordinated professionals and programs.

A treatment plan connects these services around the person. For example, one provider manages medication, another delivers individual behavioral therapy, and a support worker helps organize transport. Shared goals and scheduled reviews keep those appointments part of one course of care.

What are the main stages of drug addiction treatment?

Four stages, with the second one depending on the drug.

NIDA's research summary is that at least three months in treatment, across stages, is associated with meaningful change.

How can treatment needs differ by drug?

The substance changes the safety questions and available treatments. A program should identify practical capability for each substance rather than claim broadly that it treats all addictions.

Swipe sideways to see all columns.

NIDA emphasizes that treatment should address the person's drug use as well as related medical, psychological, social, vocational, and legal needs. See NIDA's treatment and recovery overview.

The short version by substance. Opioids (heroin, fentanyl, prescription opioids): medication is the core treatment, with buprenorphine, methadone, or naltrexone, and naloxone in the home from day one. Stimulants (cocaine, methamphetamine): no approved medication; contingency management and cognitive behavioral therapy are the treatments with evidence, and the first weeks need rest, sleep, and psychiatric monitoring. Benzodiazepines: a supervised taper, because abrupt stopping can cause seizures. Cannabis: behavioral treatment, often outpatient. Alcohol is covered separately. A program that describes the same plan for all of these has not read the assessment.

Does everyone need detox before drug rehab?

No. Withdrawal needs depend on the substance, amount, frequency, last use, prior withdrawal, other substances, medications, physical health, pregnancy, and current symptoms. Some people need medically managed withdrawal. Others can begin outpatient or residential behavioral treatment without a separate detox admission.

If someone is unconscious, breathing slowly or not breathing, having a seizure, severely confused, experiencing chest pain, or in immediate danger, call 911.

The assessment connects that history with the receiving service's staffing and medical resources.

What treatments are used in drug rehab?

Treatment methods include behavioral therapy, medication for appropriate disorders, medical and psychiatric care, family work, and practical support. Assessment determines the combination for the substance and person.

Medication availability depends on the disorder. Evidence-based opioid medication, withdrawal treatment, and medication for co-occurring conditions serve different purposes. Behavioral interventions are central where no disorder-specific medication is approved.

A calendar with named providers distinguishes a service delivered each week from an approach mentioned only in a program description.

Individual treatment

Private sessions address agreed goals involving substance use, mental health, motivation, coping, relationships, and practical decisions.

Group treatment

Group functions include education, feedback, skills practice, peer connection, and shared recovery support.

Medication services

Prescribing services address assessed needs involving opioid use disorder, withdrawal, overdose prevention, and other health conditions within their scope.

Continuing support

Continuing care includes appropriate appointments, medication, mutual support, recovery services, family plans, and changes in the home environment.

How long does drug rehab last?

There is no universal duration. Stabilization addresses acute needs, while the ongoing plan follows symptoms, functioning, safety, and response. The end of accommodation does not determine the end of clinical care.

A short program needs a strong transition plan. A long program still needs measurable goals and periodic review.

Progress reviews track practical changes such as appointment attendance, symptoms, substance use, and daily functioning. A move home changes the setting; the next schedule still needs treatment appointments, medication access where relevant, and support for the routine awaiting the person.

Typical lengths by level: residential 28 to 90 days; intensive outpatient 8 to 12 weeks at nine or more hours a week; standard outpatient months; medication for opioid use disorder often years, and stopping it is a decision with the prescriber, not a milestone. For stimulants, contingency management programs typically run 12 weeks with follow-up. For benzodiazepines, a supervised taper typically runs for months, and for long-term high-dose use can take a year or more.

What should you ask before choosing drug treatment?

A drug treatment proposal identifies the substances involved, the appropriate clinical setting, and the actual interventions. Opioid medication, stimulant behavioral treatment, and sedative withdrawal care need distinct arrangements. The weekly schedule names direct appointments, prescribing, support, and shared activities. The plan also connects mental and physical health services, records how progress is reviewed, and defines the next step when needs change. Before departure, receiving appointments, medication access, transport, and practical support should be organized around the person's circumstances at home.

Which substance-specific methods are used?

For opioids: buprenorphine, methadone, or naltrexone, plus naloxone and individual therapy. For stimulants: contingency management with a testing and incentive schedule, and cognitive behavioral therapy. For benzodiazepines: a supervised taper over weeks to months with treatment for the anxiety or insomnia underneath. A program should name which of these it delivers itself for the substance you are asking about.

Who provides medication care?

A physician, nurse practitioner, or physician assistant on the program's team or on call, or a certified opioid treatment program for methadone. The proposal should name the prescriber, say how quickly a first appointment happens, and state who continues prescribing after discharge. A program without a named prescriber is not equipped for opioid or benzodiazepine treatment.

How are changes reviewed?

Weekly in residential and intensive care, against goals set at admission: use, craving, sleep, mood, functioning, and medication response. A positive test or a missed appointment should trigger a review and more support, not a discharge. Ask who leads the review and what the options are when the plan is not working, because "more of the same" is rarely the only answer.

What follow-up is booked?

The next therapist and prescriber with first appointments dated, medication in hand at discharge with a prescriber who has agreed to continue it, naloxone if opioids are involved, contingency management continued if it is not finished, and a plan for the living situation the person returns to. Begin planning before admission and confirm the follow-up arrangements before discharge. A referral list on the last day is not follow-up.

Which drug rehab setting may fit?

Hospital care is for acute medical or psychiatric needs; residential care adds a live-in program; day treatment and intensive outpatient care provide structured appointments while living elsewhere; standard outpatient, home-based, and virtual arrangements need suitable clinical scope and support.

For example, attending an outpatient office twice a week leaves evenings and weekends in the home environment. Residential care adds a planned daily setting around those appointments. The assessment considers how that difference affects attendance and support.

The deciding questions: does the person need medical withdrawal management, a supervised benzodiazepine taper, medication for opioid use disorder, or monitoring for stimulant-related medical or psychiatric symptoms? Can the person stop using safely at home? Does anything have to keep running? Someone with a stable home, a job, and an opioid use disorder may be treated entirely as an outpatient with medication and therapy. Someone using methamphetamine daily in a household where others use it may need residential care. Someone with a public role may prefer a one-client setting and a discreet continuing-care plan. A clinical assessment decides the level of care; none of these circumstances alone is the rule.

Where to go next for your drug treatment question

• Individual treatment instead of a group program: one-on-one drug rehab.
• Privacy from an employer, a board, or a community: private drug rehab.
• Groups are the reason treatment has not happened: drug rehab without group therapy.
• Opioids, including fentanyl: opioid addiction treatment and fentanyl addiction treatment.
• Stimulants: cocaine and methamphetamine.
• Prescribed sedatives: benzodiazepine addiction treatment.

Public resources for finding substance-specific care

Swipe sideways to see all columns.

A drug treatment plan after discharge

Continuing treatment follows the substances and needs identified during care. For opioid use disorder, medication continuity and naloxone access deserve explicit arrangements. For stimulant use disorder, the next behavioral treatment and psychiatric follow-up matter. Benzodiazepine changes remain under medical supervision.

When several substances are involved, one coordinated plan is more useful than unrelated instructions from different services. It identifies the receiving clinicians and the information each needs for a safe handoff.

Booking the first follow-up before departure gives the patient a concrete next date and a place to take questions.

Common questions about drug rehab

Sources and further reading

• NIDA: Treatment and Recovery
• SAMHSA: Treatment Options for Substance Use Disorder
• FDA: Medications for Opioid Use Disorder
• FindTreatment.gov: Federal Treatment Locator
• NIDA: Principles of Drug Addiction Treatment, Third Edition
• NIDA: Medications for Opioid Use Disorder
• SAMHSA: TIP 63, Medications for Opioid Use Disorder
• FDA: Medications for Opioid Use Disorder
• CDC: Reverse Opioid Overdose to Prevent Death
• SAMHSA: Evidence-Based Contingency Management Services
• Heather Ashton: Benzodiazepines, How They Work and How to Withdraw
• NIDA: Principles of Drug Addiction Treatment

Sources checked September 7, 2026